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Abstract: Posidonia oceanica (L.) Delile is a marine plant with interesting biological properties
potentially ascribed to the synergistic combination of bioactive compounds. Our previously described
extract, obtained from the leaves of P. oceanica, showed the ability to impair HT1080 cell migration
by targeting both expression and activity of gelatinases. Commonly, the lack of knowledge about
the mechanism of action of phytocomplexes may be an obstacle regarding their therapeutic use and
development. The aim of this study was to gain insight into the molecular signaling through which
such bioactive compounds impact on malignant cell migration and gelatinolytic activity. The increase
in autophagic vacuoles detected by confocal microscopy suggested an enhancement of autophagy in
a time and dose dependent manner. This autophagy activation was further confirmed by monitoring
pivotal markers of autophagy signaling as well as by evidencing an increase in IGF-1R accumulation
on cell membranes. Taken together, our results confirm that the P. oceanica phytocomplex is a
promising reservoir of potent and cell safe molecules able to defend against malignancies and
other diseases in which gelatinases play a major role in progression. In conclusion, the attractive
properties of this phytocomplex may be of industrial interest in regard to the development of novel
health-promoting and pharmacological products for the treatment or prevention of several diseases.
Keywords: Posidonia oceanica; autophagy; cell migration; gelatinase; HT1080 cell line
1. Introduction
The angiosperm Posidonia (P.) oceanica (L.) Delile is a sea-grass widely distributed in the
Mediterranean Sea forming dense underwater meadows that cover tens to thousands of square
kilometres. In the sea coast of Western Anatolia, the decoction of P. oceanica leaves became an herbal
preparation used for diabetes mellitus and hypertension remedies. In fact, the antidiabetic and
vasoprotective properties of a P. oceanica extract have been confirmed in treated alloxan diabetic rats [1].
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Further data on the bioactivity of P. oceanica have been described, such as antibacterial and antifungal
properties as well as antimelanogenic and lypolitic activities [2] of a crude extract of leaves.
Hence, the interest in P. oceanica as a potential source of novel natural products that are useful for
the treatment or prevention of different pathological processes has greatly increased. Consequently,
the molecular mechanisms through which the bioactive compounds of P. oceanica exert their activities
need to be clarified.
In our previous work, we used UPLC analysis to characterize the polyphenolic profile of a
hydrophilic fraction of P. oceanica extract (POE), evidencing a large amount of catechins and minor
amounts of polyphenols [3] (Figure 1). Very low doses of POE showed the ability to drastically reduce
the motility of the highly invasive HT1080 fibrosarcoma cell line. This effect was due to the concomitant
presence of phenolic compounds in the total extract that synergistically decreased the expression of
gelatinases and directly inhibited gelatinolytic activity [3].
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cancers, MMPs take part in extracellular matrix degradation and cancer cell invasion and metastasis 
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Recent studies have correlated cancer cell migration with autophagy (i.e., macroautophagy), 
the major cellular digestion process conserved from yeast to mammals [5]. Autophagy process leads 
cells to digest parts and components of their own cytoplasm to overcome intracellular or 
environmental stress conditions, as nutrient deprivation or hypoxia [6,7]. 
Generally, motile and invasive cancer cells require autophagy augmentation to survive in 
stressful conditions during invasive and metastatic processes, but recently it has been proven that 
autophagy could contrast with early stages of the epithelial to mesenchymal transition (EMT) in 
which cancer cells lose typical epithelial phenotype properties and acquire motility features [8]. The 
literature reports that nutrient deprivation in glioblastoma cells impairs both migration and 
invasion and reverts EMT [9]. On the contrary, the knockdown of key autophagy inhibitors has 
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Many different signaling pathways have been described to modulate autophagy, specifically 
by influencing the activity of the mammalian target of rapamycin (mTOR), its key master regulator 
[11]. 
Phosphatidylinositol-3-kinases (PI3K) /Protein Kinase B (AKT)/mTOR and 
Ras/Raf/Mitogen-activated protein kinase/ERK kinase (MEK)/extracellular-signal-regulated kinase 
(ERK) (Ras/MEK/ERK) signal transduction pathways are well-established upstream regulators of 
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mediators of autophagy in response to extracellular stimuli [12]. AKT positively modulates mTOR 
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Gelatinases, as members of the matrix metalloproteinase MMP family, are fundamental players
in maintaining the cellular environments needed by several physiological processes. However, they
could participate in the development of important physio-pathological chronic processes, such as
neurodegeneration, inflammation and cancer development. Specifically, in cancers, MMPs take part in
extracellular matrix degradation and cancer cell invasion and metastasis making cancer cells able to
migrate and propagate [4].
Recent studies have correlated cancer cell migration with autophagy (i.e., macroautophagy),
the major cellular digestion process conserved from yeast to mammals [5]. Autophagy process leads
cells to digest parts and components of their own cytoplasm to overcome intracellular or environmental
stress conditions, as nutrient deprivation or hypoxia [6,7].
Generally, motile and invasive cancer cells require autophagy augmentation to survive in stressful
conditions during invasive and metastatic process s, but recently it has been proven that autophagy
could contrast with early stages of the epithelial to mes nchymal transition (EMT) in which cancer
ce ls lose typical epithelial phenoty e properties and cquire motility features [8]. The literature
reports that nutri nt deprivation in glioblastoma cells impairs both migration and invasion and reverts
EMT [9]. On the contrary, the knockd wn of key autophagy inhibitors has been proven to stimulate
cell migration and β-integrin recycling in HeLa cells [10].
Many different signaling pathways have been described to modulate autophagy, specifically by
influencing the activity of the mammalian target of rapamycin (mTOR), its key master regulator [11].
Phosphatidylinositol-3-kinases (PI3K) /Protein Kinase B (AKT)/mTOR and Ras/Raf/Mitogen-
activated protein kinase/ERK kinase (MEK)/extracellular-signal-regulated kinase (ERK) (Ras/MEK/ERK)
signal transduction pathways are well-established upstream regulators of mTOR, the master autophagy
suppressor. They are the main cellular mechanisms for controlling cell proliferation, survival,
differentiation, metabolism and motility and both are well-known mediators of autophagy in response
to extracellular stimuli [12]. AKT positively modulates mTOR activity and, accordingly, inhibition of
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AKT could stimulate the autophagy process by lowering mTOR activity [13] and consequently enhancing
Beclin-1 levels, one of the mTOR downstream targets. Beclin-1 is a well-established marker of the early
stages of autophagy [14] that promotes nucleation of the autophagic vesicle named the autophagosome.
During autophagosome maturation, the phosphatidylethanolamine lipidation of the protein LC3-I to
LC3-II occurs. Unlike Beclin-1, LC3-II is a marker of autophagosome full maturation that, in turn, forms
the autophagolysosome upon fusion with a lysosome. Lysosomal hydrolases then act to break down the
cargo mainly through p62 (i.e., sequestosome 1, SQTSM1), a ubiquitin-binding scaffold protein that drives
attached protein targets to autophagosomes for selective degradation (the so-called selective autophagy)
and is specifically considered a marker of the degradation phase of autophagy [15].
Beyond its known role in cell survival, the PI3K/AKT axis promotes cell migration in several
cancer cell lines, including the HT1080 cell line [16] by increasing cell motility and expression and/or
the activity of gelatinases [17]. Specifically, cell-surface insulin-like growth factor-1 receptor (IGF-1R),
which senses IGF-1 levels, is an upstream regulator of PI3K/AKT through which it enhances cell
proliferation and migration [18]. Pieces of evidence have indicated that the activated IGF-1R translocates
to the nuclei of several human cancer cells and regulates, by acting as a transcription regulator,
cancer cell migration through the modulation of MMP-2 expression [19,20]. Thus, suppression of
the IGF-1R/PI3K/AKT/mTOR signaling pathway could interfere with IGF-1R or AKT activity and
could impair cell migration by affecting the expression of gelatinases [21]. Furthermore, it has been
demonstrated that the dietary flavonoid, luteolin, reduces the migration of HT1080 cells and attenuates
the EMT process via suppression of the IGF-1R/PI3K/AKT/mTOR pathway [22].
As expected from a very basic cell process with a fundamental role in cell homeostasis, an intricate
interplay between autophagy and many other processes has been described. It is therefore useful to
refer to updated guidelines for the use and interpretation of assays for monitoring autophagy [5].
In order to better clarify our previous findings on POE effects, in this study we aimed to investigate
the role of autophagy in the inhibition of the motility of HT1080 cells. In this framework, we used
wound-healing assay, zymography, Western blotting as well as confocal microscopy to investigate
whether POE could exert, in the absence of other stimuli, its inhibitory effects on migration by
modulating autophagy without affecting cell viability.
2. Results and Discussion
2.1. Biochemical Characterization of POE
Our previous results reported that the water–ethanol extraction method is able to efficiently
recover polyphenols and carbohydrates from minced P. oceanica dried leaves [3]. In the present study,
POE was shown to contain 13 ± 2 mg/mL glucose equivalents of carbohydrates and 5.7 ± 0.3 mg/mL
gallic acid equivalents of polyphenols. Their bioactive antioxidant properties were further investigated,
evidencing radical scavenging and antioxidant activity of 12.8 ± 0.7 mg/mL and to 1.5 ± 0.3 mg/mL
ascorbic acid equivalents, respectively. These values, reported in Table 1, although slightly lower, are
in agreement with our previous report, confirming the robustness of our extraction procedure [3].
All treatments hereafter described were done with 1:500 or 1:1000 dilutions of freshly prepared
POE corresponding to polyphenol concentrations of 11.4 and 5.7 µg/mL gallic acid equivalents.
(corresponding to 67 µM and 33.5 µM), respectively.
Table 1. P. oceanica extract biochemical composition. All values are reported as means ± standard
deviations from at least three independent extractions and are expressed in mg/mL of extract after
resuspension, as described in the text.
Polyphenols Antioxidant Activity Radical Scavenging Carbohydrates
Method Folin–Ciocalteau Ferrozine® DPPH Phenol/Sulfuric acid
Reference control Gallic acid Ascorbic acid Ascorbic acid Glucose
POE 5.7 ± 0.3 1.5 ± 0.3 12.8 ± 0.7 13 ± 2
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2.2. HT1080 Cell Migration in Heat-Inactivated Fetal Bovine Serum (FBS) Medium
Classically, starvation medium condition is used to induce EMT and activate the motility features
of cells [23]. Abundant literature reports that heat inactivation of FBS (HI-FBS) markedly decreases the
levels of several plasma factors, such as MMPs, chemokines and cytokines, compared to the condition
with FBS [24]. Hence the use of HI-FBS medium decreases unwanted and unpredictable serum factors
that could interfere with various cellular processes. In our experimental set-up, the incubation of cells in
conditions such as starvation, FBS medium or HI-FBS medium allowed us to verify the innate motility
phenotype of HT1080 cells in correlation with growth conditions. By means of a wound-healing assay,
we found that the motility of HT1080 cells decreased but was not abolished in both serum-containing
conditions with respect to the starvation medium (Figure 2). In addition, the invasive potential
of cells was found to be very similar between HI-FBS and FBS media, clearly showing that the
innate motility features of HT1080 cells are maintained in non-stressful, serum-containing conditions.
Accordingly, all further experiments were based on cells grown in HI-FBS medium, so that unwanted
side effects on cellular processes were minimized while the typical motility phenotype of HT1080 cells
was maintained.
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starvation medium (bottom). Three time points are shown. HT1080 cells maintained their motility
phenotype in HI-FBS medium, a favourable condition that is not associated with a basal increase
in autophagy.
2.3. HT1080 Cell Migration Impairment Following POE Treatment
Having established that the motility phenotype of HT1080 cells was maintained in HI-FBS
medium, we performed the wound-healing assays in the presence of 1:500 and 1:1000 POE dilutions.
Both tr atments did not affect cell viability (Figure 3B) and reduced cell motility in the first seven hours
after treatment, an effect that was not present after 16 h (Figure 3A). Such results were further supported
by gelatin zymography aimed at monitoring the activity of MMP-2 and MMP-9, well-known markers
of cell migration, in conditioned media collected at different time points. The zymography analysis
showed a total gelatinase activity reduction after 1:500 and 1:1000 POE treatments. In particular,
the 1:500 and 1:1000 treatments led to an observed MMP-2 activity decrease of about 22% during
the first 7 h. A more pronounced behaviour during the same time range was found for MMP-9
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activity, with a reduction of about 35% for the first 7 h. Such trends were not observed in non-treated
control cells at the same times. Gelatinase activities were clearly recovered after 16 h POE treatments,
at any tested dose (Figure 3C). These results confirmed that the anti-invasive properties of bioactive
compounds from POE on the highly motile HT1080 cell line were, at least in part, due to a transient
reduction of gelatinase production or secretion.
Mar. Drugs 2018, 16, x 5 of 15 
 
zymography analysis showed a total gelatinase activity reduction after 1:500 and 1:1000 POE 
treatments. In particular, the 1:500 and 1:1000 treatments led to an observed MMP-2 activity 
decrease of about 22% during the first 7 h. A more pronounced behaviour during the same time 
range was found for MMP-9 activity, with a reduction of about 35% for he first 7 h. Such trends 
were not observ d in non-treated co trol ells at the sam  times. Gelatin s  activities were cl arly 
recover d after 16 h POE treatments, at any tested dose (Figure 3C). Thes  results confirmed hat 
the anti-invasive properties of bioactive compounds from POE on the highly mo ile HT1080 cell li e 
were, at least in part, due to a ra sient reduction of gelatinase production or secretion. 
 
Figure 3. (A) Wound-healing assays of HT1080 cells growing in HI-FBS medium, treated or not 
treated with 1:1000 and 1:500 POE dilutions. The dashed lines mark the boundaries of the wound 
area; (B) MTT assay showing a substantial absence of cell toxicity by POE; (C) Gelatin zymography 
of HT1080 conditioned medium collected at 1, 3, 7 and 16 h time points of HT1080 cells cultured in 
the presence or absence of 1:500 and 1:1000 POE dilutions. The ability of HT1080 cells to migrate to 
the cell-free space is drastically reduced by the addition of POE in the absence of cell toxicity, in a 
dose- and time-dependent manner influencing the production or the release of both MMP-2 and 
MMP-9. *: p-value < 0.05; **: p-value < 0.01; Student t-test, n = 3. 
Fig re 3. ( ) o - eali g assays of 1080 cells gro i g i I-F S edi , treate or not
treated ith 1:1000 and 1:500 P E dilutions. The dashed lines ark the boundaries of the ound
area; (B) TT assay showing a substantial absence of cell toxicity by POE; (C) Gelatin zymography of
HT1080 conditioned medium collected at 1, 3, 7 and 16 h time points of HT1080 cells cultured in the
presence or absence of 1:500 and 1:1000 POE dilutions. The ability of HT1080 cells to migrate to the
cell-free space is drastically reduced by the addition of POE in the absence of cell toxicity, in a dose-
and time-dependent manner influencing the production or the release of both MMP-2 and MMP-9.
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2.4. POE Treatment Induces Autophagy in HT1080 Cells
In order to examine the molecular mechanism(s) through which compounds of POE exert the
reduction of cell motility demonstrated above, we initially investigated several features and markers of
the autophagy process. In fact, recent studies have reported that cell migration could be modulated by
autophagy [8]. Firstly, we analysed HT1080 cells treated with POE using Cyto-ID® staining, a selective
fluorescent marker for autophagic vacuoles [25]. Immunofluorescence results showed a clear increase
in autophagy in HT1080 treated cells compared to untreated control cells (Figure 4). The increase
of fluorescence intensity and the number of labelled particles in treated cells suggested that POE
treatment promotes the formation of autophagosomes in the cytosol. Specifically, we observed a
significant increase in Cyto-ID® intensity of about 80% and 130% at 1:1000 and 1:500 POE dilutions
after 16 h treatment, respectively, compared to untreated cells (Figure 4B). The autophagy modulation
was confirmed by using chloroquine and rapamycin as controls. In particular, cells treated with
chloroquine did not show an increase in Cyto-ID® signal intensity, confirming its autophagy inhibitory
role [26]. On the contrary, the autophagy inducer, rapamycin [27], significantly increased the Cyto-ID®
signal after 16 h of treatment (Figure 4B).
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Cyto-ID® was analysed by confocal microscopy in HT1080 cells after 7 h and 16 h of treatment with 1:500
and 1:1000 POE dilutions. Rapamycin and chloroquine were used as positive and negative controls,
respectively. Autophagy vacuoles increased upon addition of POE in a dose- and time-dependent
manner com ared to untreated control cells (CTRL); (B) Quantificati n of Cyto-ID® fluorescence.
Autophagy significantly increased upon POE treatment in a dose- and time-dependent manner.
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Given this enabling evidence, we investigated the most common signaling pathways controlling
autophagy by Western blotting, focusing our analysis on the upstream and downstream pathways of
mTOR, the most well-known suppressive regulator of autophagy. As shown in Figure 5, we assayed
signaling pathways in HT1080 cell lysates at different times during 1:500 POE treatment, from 0.5 h
to 24 h (considering the ability of the chosen dose to consistently activate autophagy in the absence
of toxicity, as shown in Figures 4 and 3B). We showed a reduction in the phosphorylation levels
of AKT at 1 h (20 ± 16%), 3 h (15 ± 12%) and 5 h (24 ± 18%) during POE treatments. Since AKT
activation by phosphorylation is considered a pro-survival stimulus related to the PI3K/AKT/mTOR
survival pathway, the reduction we observed could be potentially ascribed to a pro-apoptotic stimulus.
We further monitored the phosphorylation status of ERK, showing an increase in the phosphorylation
levels of ERK at 1 h and 3 h, of 54 ± 10% and 66 ± 11%, respectively. The concomitant and inverse
correlations between the phosphorylation status’ of AKT and ERK is common in drug-induced
stimulation of autophagy [28–30], and it is probably one of the several feedback mechanisms involving
pathways fundamental for cellular homeostasis. After 7 h of treatment, the effect of the AKT activity
reduction led to a decrease in S6 phosphorylation (14 ± 11%), one of the main targets used to monitor
mTOR activity as a mainstream inhibitor of autophagy. At this time point, AKT maintained a low level
of phosphorylation (26 ± 38%) while ERK phosphorylation returned to control levels. At the 16 h time
point, AKT recovered its baseline phosphorylation status while both ERK and S6 phosphorylation
continued to decline, as evidenced after 24 h of treatment. We further investigated the dynamics of
Beclin-1 levels, since this alteration is considered a crucial event for the initial step of autophagosome
formation (so, a downstream event in the autophagic signaling cascade) and therefore, a marker of
effective activation of the autophagy process. We observed a progressive increase from 0.5 h up to a
peak of activation after 7 h of treatment (206 ± 12%) with Beclin-1, supporting the observed autophagy
enhancement. At the 7 h time point, we further showed initial traces of autophagosome maturation,
as supported by a slight increase in the conversion of LC3-I to LC3-II (the lipidated form) (86 ± 8%),
a well-accepted marker of lengthening of the autophagosome. The level of p62 protein, a marker
of the degradation phase of autophagy, proved to be substantially unchanged with respect to the
untreated control at this 7 h time point, suggesting that the autophagolysosome formation was in its
early stage. At the 16 h time point, we detected clear signs of full autophagolysosome formation, with a
net reduction in Beclin-1 (that remained unchanged until 24 h, the latest time point we measured),
a marked rise in the levels of LC3-II lipidation and a net reduction inp62 protein levels (35 ± 3%).
It is important to underline that the kinetics of the autophagy process activation upon POE treatment
in all of the above-mentioned markers is in agreement with the results obtained with the Cyto-ID®
analysis. In fact, the highest level of Beclin-1 was established at 7 h and correlated well with the initial
autophagosome formation that was already evident at 7 h in the Cyto-ID® results. The concomitant
decrease in Beclin-1, the marked presence of the LC3-II lipidated form and the fall in the p62 protein
level after 16 h of POE treatment suggested that the autophagy process was fully mature. This further
supports the evidence for the effective maturation of autophagolysosomes, reinforcing the results
obtained with Cyto-ID® (Figure 4), which in fact is reported to co-localize with LC3 [31].
2.5. Autophagy Modulation by POE Decreases Cell Migration
Observed autophagy modulation by POE treatment could contribute to the HT1080 cell migration
reduction that we described above. Recent studies have reported the existence of a correlation between
autophagy and cell migration. In particular, AKT phosphorylation and the consequent signaling is
described as being positively correlated with cell motility and gelatinase activation. Our results show
that POE treatment causes a reduction in motility and a reduction in MMP-2/9 activity, concomitant
with the reduction in AKT phosphorylation. The literature further reports that MMP-2 expression, and
thus, cell migration, can be regulated by IGF-1R which translocates into the cell nucleus in response to
PI3K/AKT signaling [17]. We therefore investigated, by confocal microscopy, the relationships between
the cell membrane and nuclear accumulation of IGF-1R in untreated cells or cells treated with POE
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1:500. It is important to re-emphasize here that HT1080 cells are widely used as a model of cancer cell
migration due to their extremely motile phenotype. Our analysis showed complete accumulation of
IGF-1R in the nuclei of untreated cells, confirming its association with motility in this cell line (Figure 6).
After 0.5 h of POE treatment, cells showed a marked IGF-1R nuclear localization and consequently,
a redistribution on the cell membrane, in particular after 3 h of treatment. The documented early
increase in IGF-1R redistribution on the cell surface was found to be reduced at 7 h and fully abolished
after 16 h of treatment, confirming that the POE effect was transient and lasted for a few hours only. Our
kinetic data regarding IGF-1R accumulation was found to be perfectly coherent with the autophagy
signaling data shown above and, more importantly, with the overall change in cell phenotype and
behaviour upon POE treatment.
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Figure 5. Western blotting analysis of the status of autophagy markers in HT1080 cells following 1:500
POE treatment. (A) Representative Western blots of all of the assayed markers; (B) Quantification
of signals from a densitometry analysis of at least three independent experiments. Error bars
represent standard errors. POE treatment reduces AKT and S6 phosphorylation and incr ases ERK
phosphorylation at the early stages of the HT1080 cell response, while, at late stages, an inverse trend
can be observed for AKT and ERK. Beclin-1 progressively increases, reaching the highest peak at 7 h.
The LC3-II form increases only at the late stages of the response with a concomitant decrease in p62.
◦: p-value < 0.1; *: p-value < 0.05; **: p-value < 0.01; ***: p-value < 0.001; Wilcoxon test, n = 3.
We further investigated the relationship between POE-induced autophagy and its effect on
cell migration by adding chloroquine, which blocks lysosome acidification, i.e., the last step of the
autophagy process. We recorded cell migration in a time-lapse wound-healing assay, and we found
that, as depicted in Figure 7, the presence of POE determined a stall in wound area closure kinetics
after 7 h, in contrast to what was observed in untreated controls (in agreement with the zymographic
data shown in Figure 3). The addition of chloroquine at 7 h in POE treated cells, the most relevant time
point for autophagy activation, showed a recovery of the motility phenotype. Taken together, such
results demonstrate that the effects of POE on cell migration impairment occur through the modulation
of the autophagy process.
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Figure 6. Immunofluorescence analysis of cell-surface insulin-like growth factor-1 receptor (IGF-1R)
localization. HT1080 cells untreated (CTRL) or treated with 1:500 POE for 0.5 h, 3 h, 7 h and 16 h.
(A) Merging of differential interference contrast (DIC) and IGF-1R staining with Alexa 488 (green)
channels; (B) Alexa 488 (green) channel; (C) Magnification of selected areas of panel B, showing details
of IGF-1R localization within cells.
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3. Materials and Methods
3.1. Materials
3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-4′,4”-disulfonic acid sodium salt (Ferrozine®),
α,α-diphenyl-β-picrylhydrazyl (DPPH), Folin–Ciocalteau’s phenol reagent, gallic acid, ascorbic acid,
D-glucose, gelatin, Coomassie Brilliant Blue R-250, 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan
(MTT), Dulbecco’s Modified Eagle’s Medium (DMEM), Fetal Bovine Serum (FBS) and Bovine
Serum Albumin (BSA) were all purchased from Sigma Aldrich-Merck (St. Louis, MO, USA).
30% Acrylamide/Bis 37.5:1 solution, ammonium persulfate (APS), 1,2-Bis (dimethylamino) ethane
(TEMED), Tris/Glycine buffers, nitrocellulose membranes (0.45 µM) blotting membranes and
Clarity Western ECL solution were purchased from Bio-Rad. Disposable plastics were from Corning.
Photometric measurements from multi-well plates were recorded on an iMARK microplate reader
(Bio-Rad, Hercules, CA, USA). When not otherwise specified, all chemicals and solvents, such as
ethanol, methanol and n-hexane, were of the highest analytical grade and were purchased from
Sigma Aldrich-Merck.
3.2. Preparation of P. oceanica Extract
The collection of P. oceanica (L.) Delile and the extraction of its hydrophilic components were
performed using a previously-described protocol [3]. Briefly, dried P. oceanica leaves (collected in
July 2016) were minced and suspended overnight in 10 mL of ethanol (70% per gram of leaves)
under stirring conditions at 65 ◦C for 3 h. P. oceanica ethanol extract was separated from debris by
centrifugation, and the supernatant was mixed in a 1:1 ratio. Hydrophobic compounds were removed
by repeatedly shaking, while hydrophilic compounds were mainly contained in the cleaned and
recovered phase of the extract and subsequently, were dispensed in aliquots of 1 mL. Batches of the
extract were dried by a Univapo™ vacuum-spin concentrator, and then single batches were dissolved
in 0.5 mL 70% ethanol in sterile water before use.
3.3. Determination of Total Polyphenol Content
The total polyphenol content of POE was determined according to the colorimetric
Folin–Ciocalteau method [32]. Scalar volumes of POE were dispensed in a 96-well microplate and
diluted with H2O (final volume 20 µL). Then, 100 µL of the Folin–Ciocalteu’s phenol reagent (diluted
1:10 in H2O) was added to each well. After 5 min of incubation at room temperature (RT), 80 µL of 7.5%
sodium carbonate solution was added per well and incubated for further 2 h. The absorbance at 595
nm was recorded with a microplate reader. Polyphenol content was determined by linear regression
using gallic acid as a reference in the range of 0–10 µg.
3.4. Determination of Total Carbohydrate Content
The total carbohydrate content of POE was determined according to the phenol–sulfuric acid
method [33]. Briefly, scalar aliquots of POE were added to a 96-well microplate and diluted with H2O
(final volume 50 µL), and then 150 µL of concentrated sulfuric acid was added to each well. After
5 min of incubation at RT under continuous shaking, 30 µL of 5% phenol solution was added to each
well and heated for 10 min at 90 ◦C. After cooling to room temperature for 20 min, the absorbance at
490 nm was recorded with a microplate reader. The carbohydrate content was determined by linear
regression using D-glucose as a reference in the range of 0–50 µg.
3.5. Determination of Radical Scavenging Activity
The radical scavenging activity of POE was determined by adapting the method from Fukumoto
and Mazza [34]. Briefly, scalar aliquots of POE were diluted with 95% methanol (final volume 100 µL)
and then mixed with 100 µL of freshly prepared DPPH solution (0.15 mg/mL in 95% methanol) in
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a 96-well microplate. After 30 min of incubation at RT in the dark, the absorbance was recorded at
490 nm with a microplate reader. Radical scavenging activity was determined by linear regression
using ascorbic acid as a reference in the range of 0–4 µg.
3.6. Determination of Total Antioxidant Activity
The total antioxidant activity of POE was estimated using the FRAP (ferric-reducing/antioxidant
power) method [35]. Briefly, scalar aliquots of POE were diluted with water (final volume 50 µL) and
200 µL of Ferrozine™ reagent (10 mM Ferrozine™ in 40 mM HCl:20 mM ferric chloride:0.3 M acetate
buffer pH 3.6, ratio 1:1:10) was added to each aliquot in a 96-well microplate. After 5 min of incubation
at RT in the dark, the absorbance was measured at 595 nm with a microplate reader. Antioxidant
activity was determined by linear regression using 0.1 mg/mL ascorbic acid as a reference in the range
of 0–4 µg.
3.7. Cell Line and Culture Conditions
The HT1080 human fibrosarcoma cell line was grown in DMEM (Dulbecco’s Modified Eagles
Medium) supplemented with 2 mM L-glutamine, 100 µg/mL streptomycin, 100 U/mL penicillin and
10% fetal bovine serum (FBS medium), at 37 ◦C in a 5% CO2-humidified atmosphere. At 90% confluence,
cells were detached by trypsinization (trypsin 0.025%-EDTA 0.5 mM) and propagated after appropriate
dilution. Medium supplemented with FBS was inactivated at 56 ◦C for 30 min (HI-FBS medium),
and serum-free medium (starvation medium) was used for some of the following experiments. HT1080
cells were grown in the presence or absence of freshly-dissolved POE and appropriate controls.
3.8. Cell Viability Assay
Cell viability was assessed using the colorimetric 3-(4,5-dime-thylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) metabolic activity assay after different cell treatment conditions [36]. In brief, cells were
grown in a 24-well plate (5× 105 cells/well) in HI-FBS medium for 24 h. Then, cells were treated with two
different POE dilutions, 1:500 and 1:1000, for 16 h and 24 h, while untreated cells were used as a control.
After removing the incubation medium and washing with PBS, 200 mL/well of 0.5 mg/mL MTT solution
was added and incubated in the dark at 37 ◦C for 1 h. Next, after PBS washing, cells were lysed in 200 µL
dimethyl sulfoxide (DMSO) and absorbance values were measured at 595 nm with a microplate reader.
Data were expressed in terms of percentage with respect to untreated controls.
3.9. Cell Migration Assay
Cell migration was assayed using the scratch wound healing assay. HT1080 cells were seeded in
12-well plates at a high density (5× 105 cells/well) and grown to confluence overnight in three different
culture media, namely FBS medium, HI-FBS medium and starvation medium, with or without POE
treatment. Next, we made a vertical wound through the cell monolayers using a sterile plastic tip, and
plates were washed several times with PBS to remove cell debris and medium. Fresh culture media was
added again, and then the cell-free area was observed under phase contrast microscopy, and images
were captured at time points ranging from 0 h to 16 h using a Nikon TS-100 microscope equipped
with a digital acquisition system (Nikon Digital Sight DS Fi-1, Nikon, Minato-ku, Tokyo). Time-lapse
experiments were performed by seeding 1 × 106 cells on 10 cm2 culture plates and culturing them
in HI-FBS medium supplemented with 20 mM HEPES in order to maintain the desired pH without
requiring CO2. Cells were treated with and without POE (1:500). After 7 h of incubation with POE,
the medium was supplemented with chloroquine (10 µM). The wounded cell-free area was observed
under phase contrast microscopy for 24 h at 37 ◦C. Three frames from the same optical field were
captured every 5 min by time-lapse recording, and wound size was analyzed with TScratch software
(ETH CSElab, Zurich, Switzerland) and further processed with R statistical software.
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3.10. Gelatin Zymography
Gelatinase activity was assayed by gelatin zymography using conditioned medium from HT1080
cell cultures previously seeded at a density of 2 × 105 cells/well in 24-well culture plates and incubated
in FBS medium for 18 h. Subsequently, culture medium was removed, and cells were incubated in
HI-FBS medium following addition of 1:500 and 1:1000 POE dilutions for up to 16 h, while untreated
cells were used as a control. After these incubation time points, culture supernatants were collected and
centrifuged at 9700× g for 1 min at 4 ◦C in order to pellet cell debris. Then, 2.5 µL aliquots of conditioned
medium from control or POE treated HT1080 cells were electrophoresed under non-reducing conditions
in 8% polyacrylamide gels containing 1 mg/mL gelatin. After the electrophoretic separation, gels were
washed twice in 2.5% Triton X-100 for 1 h to remove SDS and then incubated at 37 ◦C for 24 h in reaction
buffer (50 mM Tris-HCl pH 7.4, 0.2 M NaCl, 5 mM CaCl2, 1 µM ZnCl). Gels were stained with 0.05%
Colloidal Coomassie Brillant Blue G-250 dissolved in 1.6% phosphoric acid, 8% ammonium sulfate and
20% methanol and destained in 1% acetic acid. Gelatinase activities appeared as clear bands against a
blue background. Zymography images were acquired with a digital scanner.
3.11. Analysis of Autophagic Vacuoles
The Cyto-ID® Autophagy Detection Kit (Enzo Life Sciences, Shanghai, China) was used to monitor
the induction of autophagy using fluorescence microscopy, in accordance with the manufacturer’s
instructions. Cyto-ID® dye selectively labelled the autophagic vacuoles in living cells, so HT1080
cells (5 × 104 cells/well) were seeded for 24 h in a 24-well culture plate containing sterilized glass
coverslips. Following treatments for 7 and 16 h with 1:500 and 1:1000 POE dilutions, as well as 0.5 µM
of rapamycin and 10 µM of chloroquine as positive and negative controls, respectively, cells were
washed twice with PBS and then with 100 µL of 1× Assay Buffer provided with the detection kit.
Then, cells were incubated for 30 min at 37 ◦C with 100 µL of dual detection reagent (prepared
by diluting Cyto-ID® Green Detection Reagent 330 times in a mixture of 1× Assay Buffer), protected
from light. Finally, cells were fixed with 2% paraformaldehyde for 20 min and washed three times
with the 1× Assay Buffer. Then coverslips were placed on microscope slides using a Fluoromount™
Aqueous Mounting Medium (Sigma Aldrich-Merck). Fluorescent signals were visualized using a Leica
TCS SP5 confocal scanning microscope (Leica, Mannheim, Germany) equipped with a HeNe/Ar laser
source to allow fluorescence measurements at 488 nm. The cell observations were performed using
a Leica Plan 7 Apo X63 oil immersion objective, suited with optics for DIC acquisition. Cells from
three independent experiments and three different fields (about 20 cells/field) per experiment were
analysed. The fluorescence intensity was analysed with the ImageJ software (Image 1.51j8 version,
National Institutes of Health Bethesda, Bethesda, MD, USA), and expressed as percentage increase
respect to untreated cells.
3.12. Analysis of IGF-1R Localization
HT1080 cells were plated at a density of 5 × 104 cells per well in a 24-well culture plate containing
sterilized glass coverslips and grown for 24 h. Next, cells were treated with 1:500 POE dilution for
0.5, 3, 7 and 16 h, fixed with 2% paraformaldehyde for 5 min and permeabilized with ice cold 50%
acetone/50% ethanol solution for 4 min at RT. After PBS washing, cells were blocked in saturated
solution (0.5% BSA and 2% gelatin) for 30 min at 37 ◦C. After 1 h of incubation at 37 ◦C with a mouse
anti-IGF-1R monoclonal antibody (Cell Signaling) diluted to 1:100 in saturated solution, cells were
washed with PBS for 30 min under stirring conditions and then incubated with Alexa 488-conjugated
anti-mouse secondary antibody (Invitrogen Molecular Probes) diluted to 1:200 in PBS for 1 h at 37 ◦C in
the dark. Finally, cells were washed twice with PBS, and coverslips were placed onto microscope slides
using a Fluoromount™ Aqueous Mounting Medium. Fluorescent signals were visualized using a
Leica TCS SP5 confocal scanning microscope (Leica, Mannheim, Germany) equipped with a HeNe/Ar
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laser source for fluorescence measurements. The observations were performed using a Leica Plan 7
Apo X63 oil immersion objective, suited with optics for DIC acquisition.
3.13. Detection of Autophagy Markers
HT1080 cells (2 × 105 cells) were seeded in 60 mm dishes in HI-FBS medium condition and
were incubated for 24 h. Subsequently, cells were treated with 1:500 POE dilution and after PBS
washing they were lysed at different time points, ranging from 0.5 h to 24 h, in 150 µL of Laemmli
buffer (62.5 mM Tris-HCl pH 6.8, 10% (w/v) SDS, 25% (w/v) glycerol) without bromophenol blue.
The protein concentration of lysates was measured by a BCA protein assay. Equal amounts of cellular
lysates (15 µg), added with β-mercaptoethanol and bromophenol blue, were resolved by 12% PAGE
and transferred onto nitrocellulose membranes. After blocking with 5% (w/v) BSA in 0.1% (v/v)
PBS-Tween-20 for 1 h, membranes were incubated overnight at 4 ◦C with the primary antibodies
of specific protein markers involved in autophagy signaling listed in Table 2. Then, nitrocellulose
membranes were washed three times in 0.1% (v/v) PBS-Tween-20 and were incubated for 1 h with
specific goat anti-rabbit (Invitrogen Molecular Probes) and goat anti-mouse secondary antibodies
(Invitrogen Molecular Probes) at a dilution of 1:10,000 in blocking buffer. After washing in 0.5%
(v/v) PBS-Tween-20, specific protein bands were detected using Clarity Western ECL solution, and
chemiluminescent signals were acquired by using Amersham TM 600 Imager (GE Healthcare Life
Science, Pittsburgh, PA, USA) imaging system. Immunoreactive bands were quantified by Quantity
One software (4.6.6 version, Bio-Rad).
Table 2. Primary antibodies used in Western blotting experiments.
Antibody Target Dilution Host Source
SQTSM1/p62 SQTSM1/p62 protein 1:1000 Rabbit Abcam
LC3A/B Microtubule-associated protein light chain 3 (A/B) 1:1000 Rabbit Cell Signaling
P-AKT1 P-AKT1 serine/threonine kinase (Ser473) 1:5000 Rabbit Abcam
AKT1/2 AKT1/2 serine/threonine kinase 1:5000 Rabbit Abcam
p44/42 MAPK(ERK1/2) Mitogen-activated protein kinases p44/42 (ERK 1/2) 1:2000 Mouse Cell Signaling
P-p44/42 MAPK(ERK 1/2) Mitogen-activated protein kinases p44/42 (ERK 1/2)(Thr202/Thr204) 1:1000 Rabbit Cell Signaling
Beclin-1 Beclin-1 protein 1:1000 Rabbit Cell Signaling
S6 Ribosomial protein S6 1:1000 Rabbit Cell Signaling
P-S6 Ribosomial protein S6 (Ser235/236) 1:2000 Rabbit Cell Signaling
Alpha-Tubulin Alpha-Tubulin protein 1:1000 Mouse Cell Signaling
Actin Actin protein 1:1000 Mouse Santa Cruz
3.14. Data Analysis and Figure Preparation
Where not otherwise specified, data are reported as the mean ± standard error of values from
three independent experiments, after mean centering as a normalizing strategy across experiments.
Plots were drawn with LibreOffice Calc, and panels were assembled with LibreOffice Impress and
further adapted with Gimp 2.8.
4. Conclusions
In this work, we evaluated the contribution of autophagy to the previously demonstrated
reduction of cell migration after POE treatment [3]. After verifying that the HT1080 cell line,
a well-known model of cell migration, exhibits a motility phenotype in the absence of starvation
(it was important in order to avoid a basal increase in autophagy), we demonstrated that the effects of
POE compounds on motility reduction are highly correlated with a transient autophagy increase that
has no detectable effect on cell viability.
Usually, the mechanisms of action of anti-cancer drugs are based essentially on the differential
cell toxicity and sensibility of actively growing cancer cells with respect to normal cells. Our results
demonstrate the potential of POE bioactive compounds to work against cell invasion (e.g., metastasis)
with a completely non-toxic mechanism. P. oceanica decoction has been historically used as a vitalizer
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and traditional remedy for diabetes in Anatolia villages, and the administration of P. oceanica extract
to rats showed no signs of toxicity [1]. Further studies will be needed to confirm the absence
of POE toxicity in humans under experimentally controlled conditions and, more importantly,
to establish its anti-metastatic effects in vivo. Nevertheless, this work documents important potential
therapeutic properties of P. oceanica compounds regarding the prevention of malignancies and other
physio-pathological chronic processes, such as neurodegeneration, inflammation and skin aging,
in whose progression gelatinolytic activity is the hallmark.
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